Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM1 | P11309 | 1/20 | 0.36 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.36 |
| ▸ | BUB1 | O43683 | 5/20 | 0.34 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.34 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.33 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
| ▸ | PTGES | O14684 | 1/20 | 0.32 |
| ▸ | JAK2 | O60674 | 1/20 | 0.32 |
| ▸ | JAK3 | P52333 | 1/20 | 0.32 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.32 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | METAP2 | P50579 | 1/20 | 0.32 |
| ▸ | F2RL3 | Q96RI0 | 1/20 | 0.32 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.32 |
| ▸ | TDO2 | P48775 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14849027 | 0.84 | MAOB (0.41) | BUB1CYP17A1MAOAF2RL3AAK1 | |
| SCHEMBL14840861 | 0.83 | CYP1A2 (0.46) | PIM1PIM2PTGESCYP1A2METAP2 | |
| SCHEMBL1025333 | 0.82 | AGPAT2 (0.41) | PTGESAAK1 | |
| SCHEMBL14840456 | 0.78 | PIM1 (0.43) | PIM1PIM2FFAR1CYP11B2MAOA | |
| SCHEMBL14840893 | 0.77 | PIM1 (0.42) | PIM1PIM2FFAR1MAOACYP19A1 | |
| SCHEMBL12071096 | 0.76 | PIM1 (0.42) | PIM1PIM2FFAR1MAOA | |
| SCHEMBL14841414 | 0.76 | PIM1 (0.37) | PIM1PIM2FFAR1MAOAGRM4 | |
| SCHEMBL1026375 | 0.74 | SGMS2 (0.34) | BUB1CYP17A1CYP1A2METAP2 | |
| SCHEMBL14840290 | 0.74 | PIM1 (0.39) | PIM1PIM2FFAR1CYP17A1MAOA | |
| SCHEMBL1023499 | 0.72 | AGPAT2 (0.43) | AAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8796306-B2 | Noxious arthropod controlling composition and heterocyclic compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-08-05 | — | — | US | disclosed |
| US-8796306-B2 | Noxious arthropod controlling composition and heterocyclic compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-08-05 | — | — | US | disclosed |
| US-20130090353-A1 | NOXIOUS ARTHROPOD CONTROL COMPOSITION AND HETEROCYCLIC COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-04-11 | — | — | US | disclosed |
| US-20130090353-A1 | NOXIOUS ARTHROPOD CONTROL COMPOSITION AND HETEROCYCLIC COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-04-11 | — | — | US | disclosed |
| CN-103037694-A | Harmful arthropod-controlling composition and heterocyclic compound | SUMITOMO CHEMICAL CO | 2013-04-10 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130090353-A1 | NOXIOUS ARTHROPOD CONTROL COMPOSITION AND HETEROCYCLIC COMPOUND | C5, C3AR1, TRPA1 | PIM1 4830/4885PIM2 4859/4885BUB1 3411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.